1. Pembrolizumab
   , 2022, Reactions Weekly CrossRef
2. Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review
   Ranferi Ocaña-Guzmán et al, 2023, Pharmaceuticals CrossRef